162 related articles for article (PubMed ID: 27478784)
21. Blends of enteric and GIT-insoluble polymers used for film coating: physicochemical characterization and drug release patterns.
Lecomte F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
J Control Release; 2003 May; 89(3):457-71. PubMed ID: 12737848
[TBL] [Abstract][Full Text] [Related]
22. Influence of film additives on stabilizing drug release rates from pellets coated with acrylic polymers.
Maejima T; McGinity JW
Pharm Dev Technol; 2001; 6(2):211-21. PubMed ID: 11416995
[TBL] [Abstract][Full Text] [Related]
23. When drugs plasticize film coatings: Unusual formulation effects observed with metoprolol and Eudragit RS.
Karrout Y; Siepmann F; Benzine Y; Paccou L; Guinet Y; Hedoux A; Siepmann J
Int J Pharm; 2018 Mar; 539(1-2):39-49. PubMed ID: 29337184
[TBL] [Abstract][Full Text] [Related]
24. [Preparation and properties of sustained-release pellets of glycyrrhizin effective components].
Chen LH; Feng Y; Xu DS; Li JS; Zhang L; Wang YH
Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):509-13. PubMed ID: 18536370
[TBL] [Abstract][Full Text] [Related]
25. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
Akhgari A; Sadeghi F; Garekani HA
Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
[TBL] [Abstract][Full Text] [Related]
26. An organic acid-induced sigmoidal release system for oral controlled-release preparations. 2. Permeability enhancement of Eudragit RS coating led by the physicochemical interactions with organic acid.
Narisawa S; Nagata M; Hirakawa Y; Kobayashi M; Yoshino H
J Pharm Sci; 1996 Feb; 85(2):184-8. PubMed ID: 8683446
[TBL] [Abstract][Full Text] [Related]
27. Studies of pectin HM/Eudragit RL/Eudragit NE film-coating formulations intended for colonic drug delivery.
Semdé R; Amighi K; Devleeschouwer MJ; Moës AJ
Int J Pharm; 2000 Mar; 197(1-2):181-92. PubMed ID: 10704805
[TBL] [Abstract][Full Text] [Related]
28. Coatings of Eudragit® RL and L-55 Blends: Investigations on the Drug Release Mechanism.
Wulff R; Leopold CS
AAPS PharmSciTech; 2016 Apr; 17(2):493-503. PubMed ID: 26265188
[TBL] [Abstract][Full Text] [Related]
29. Preparation of the traditional Chinese medicine compound recipe heart-protecting musk pH-dependent gradient-release pellets.
Song H; Guo T; Zhang R; Zheng C; Ma Y; Li X; Bi K; Tang X
Drug Dev Ind Pharm; 2002 Nov; 28(10):1261-73. PubMed ID: 12476872
[TBL] [Abstract][Full Text] [Related]
30. Pectin/chitosan/Eudragit RS mixed-film coating for bimodal drug delivery from theophylline pellets: preparation and evaluation.
Ghaffari A; Oskoui M; Helali K; Bayati K; Rafiee-Tehrani M
Acta Pharm; 2006 Sep; 56(3):299-310. PubMed ID: 19831279
[TBL] [Abstract][Full Text] [Related]
31. Comparison of 5-ASA layered or matrix pellets coated with a combination of ethylcellulose and eudragits L and s in the treatment of ulcerative colitis in rats.
Sardou HS; Sadeghi F; Garekani HA; Akhgari A; Hossein Jafarian A; Abbaspour M; Nokhodchi A
Int J Pharm; 2023 Jun; 640():122981. PubMed ID: 37120124
[TBL] [Abstract][Full Text] [Related]
32. Influence of the Component Excipients on the Quality and Functionality of a Transdermal Film Formulation.
Saoji SD; Atram SC; Dhore PW; Deole PS; Raut NA; Dave VS
AAPS PharmSciTech; 2015 Dec; 16(6):1344-56. PubMed ID: 25922089
[TBL] [Abstract][Full Text] [Related]
33. Determination of the release mechanism of Theophylline from pellets coated with Surelease
Kazlauske J; Cafaro MM; Caccavo D; Marucci M; Lamberti G; Barba AA; Larsson A
Int J Pharm; 2017 Aug; 528(1-2):345-353. PubMed ID: 28583332
[TBL] [Abstract][Full Text] [Related]
34. Preparation and characterization of ibuprofen pellets based on Eudragit RS PO and RL PO or their combination.
Abbaspour MR; Sadeghi F; Garekani HA
Int J Pharm; 2005 Oct; 303(1-2):88-94. PubMed ID: 16153792
[TBL] [Abstract][Full Text] [Related]
35. The Effect of Thermal-Treating on Drug Release from Sustained Release Alginate-Eudragit RS Matrices.
Kaffash E; Abbaspour M; Afrasiabi Garekani H; Jahanian Z; Saremnejad F; Akhgari A
Adv Pharm Bull; 2021 Feb; 11(2):318-326. PubMed ID: 33880354
[No Abstract] [Full Text] [Related]
36. [The effect of polymeric dispersion type on the release of diclofenac sodium from coated pellets].
Krejcová K; Rabisková M; Vetchý D; Tomásek V; Prokopová A
Ceska Slov Farm; 2007 Jul; 56(4):190-9. PubMed ID: 17969318
[TBL] [Abstract][Full Text] [Related]
37. Formulation and characterization of a compacted multiparticulate system for modified release of water-soluble drugs--Part II theophylline and cimetidine.
Cantor SL; Hoag SW; Augsburger LL
Drug Dev Ind Pharm; 2009 May; 35(5):568-82. PubMed ID: 18979306
[TBL] [Abstract][Full Text] [Related]
38. Study of crystallization of endogenous surfactant in Eudragit NE30D-free films and its influence on drug-release properties of controlled-release diphenhydramine HCl pellets coated with Eudragit NE30D.
Lin AY; Muhammad NA; Pope D; Augsburger LL
AAPS PharmSci; 2001; 3(2):E14. PubMed ID: 11741265
[TBL] [Abstract][Full Text] [Related]
39. Preparation and In Vitro Evaluation of Ethylcellulose and Polymethacrylate Resins Loaded Microparticles Containing Hydrophilic Drug.
Pandav S; Naik J
J Pharm (Cairo); 2014; 2014():904036. PubMed ID: 26556206
[TBL] [Abstract][Full Text] [Related]
40. [Preparation of tetrandrine alginate calcium sustained release gel pellets].
Ma Y; Li WZ; Chen DW
Zhong Yao Cai; 2008 Jan; 31(1):131-4. PubMed ID: 18589765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
